MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3, a Potential New ...

Retrieved on: 2021-01-27 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

MGB Biopharma - Successful End-of-Phase 2 Meeting with FDA for MGB-BP-3, a Potential New .... View article details on hiswai:

Excerpt

GLASGOW, Scotland, Jan. 27, 2021 /PRNewswire/ -- MGB Biopharma, a biopharmaceutical company developing MGB-BP-3, a novel antibacterial, for ...

Article found on: www.prnewswire.com